Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma

Overview of attention for article published in Blood, May 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 52 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 15,542 followers.

Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma. https://t.co/FIxYqcJvph

Recurrent MSCE116K mutations in ALK-negative anaplastic large cell #lymphoma | ⁦@BloodJournal⁩ #lymsm https://t.co/Mo1SyeHhX9

Recurrent MSC mutaiton https://t.co/cYEkzez5N6 as a key #driver of the CD30-IRF4-MYC axis in ALK-negative #anaplastic large cell #lymphoma https://t.co/zOLqyA7k7Z

Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma. https://t.co/hYwIXw5wYW

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.